Sign in
4

Changes in Ownership

ANAPTYSBIO, INC Filed Acc 0001209191-21-070986

President, CEO sold 36,645 shares at an average $35.57 ($1,303,559)

  • President, CEO acquired 36,645 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Suria Hamza President, CEO 2021-12-20 Option exercise +36,645 $1.12 $41,042 105,245 D: show line 1 in the form
Suria Hamza President, CEO 2021-12-20 Sale −11,915 $34.89 $415,756 93,330 D: show line 2 in the form
Suria Hamza President, CEO 2021-12-20 Sale −19,208 $35.75 $686,776 74,122 D: show line 3 in the form
Suria Hamza President, CEO 2021-12-20 Sale −5,522 $36.40 $201,026 68,600 D: show line 4 in the form
Open-market sales · 36,645 sh · avg $35.57 · $1,303,559

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Suria Hamza President, CEO 2021-12-20 Option exercise · Employee Stock Option (Right to Buy) −36,645 0 D: show line 5 in the form
Loading xslF345X03/doc4.xml…